title: Evaluation of cyclodextrin solubilization of drugs.
abstract: The most common stoichiometry of drug/cyclodextrin complexes is 1:1, i.e. one drug molecule forms a complex with one cyclodextrin molecule, and the most common method for stoichiometric determination during formulation studies is the phase-solubility method. However, in recent years it has becoming increasingly clear that solubilizing effects of cyclodextrins are frequently due to the formation of multiple inclusion and non-inclusion complexes. The aqueous solubility of 38 different drugs was determined in pure aqueous solution, aqueous buffer solutions and aqueous cyclodextrin solutions, and the apparent stability constant (K1:1) of the 1:1 drug/cyclodextrin complexes calculated by the phase-solubility method. For poorly soluble drugs (aqueous solubility <0.1mM) the intrinsic solubility (S0) is in general much larger than the intercept of the phase-solubility diagram (Sint) resulting in non-linearity of otherwise linear (AL-type) phase-solubility diagram. This can lead to erroneous K(1:1)-values. A more accurate method for determination of the solubilizing efficiency of cyclodextrins is to determine their complexation efficiency (CE), i.e. the concentration ratio between cyclodextrin in a complex and free cyclodextrin. CE is calculated from the slope of the phase-solubility diagrams, it is independent of both S0 and Sint, and more reliable when the influences of different pharmaceutical excipients on the solubilization are being investigated.
authors.affiliation: Faculty of Pharmacy, University of Iceland, Hofsvallagata 53, IS-107 Reykjavik, Iceland. thorstlo@his.is
authors.forename: Thorsteinn
authors.initials: T
authors.lastname: Loftsson
authors.forename: Dagný
authors.initials: D
authors.lastname: Hreinsdóttir
authors.forename: Már
authors.initials: M
authors.lastname: Másson
mesh_terms: D000465:Algorithms; D003505:Cyclodextrins / Q000737:chemistry*; D004355:Drug Stability; D005079:Excipients / Q000737:chemistry; D007700:Kinetics; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D012995:Solubility; D012996:Solutions / Q000737:chemistry; D013678:Technology, Pharmaceutical / Q000379:methods
chemical_list: D003505:Cyclodextrins; D005079:Excipients; D004364:Pharmaceutical Preparations; D012996:Solutions